Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626210 · ClinicalTrials.gov registry record · Phase 4
Modafinil Treatment for Sleep/Wake Disturbances in Older Adults
A Phase 4 study, sponsored by VA Palo Alto Health Care System.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT00626210 is a Phase 4 study that was terminated before completion, run by VA Palo Alto Health Care System. The registered enrollment target is 2 participants.
The verdict
NCT00626210, a Phase 4 study, was terminated before completion, sponsored by VA Palo Alto Health Care System.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
Modafinil, trade named Provigil, is a medication approved by the Food and Drug Administration for the treatment of narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. Each of these problems is characterized by difficulty sleeping at night and excessive daytime sleepiness. Modafinil is prescribed during the day to counteract this sleepiness. The idea behind this treatment is that sleepiness that leads to napping during the day prevents a patient from being tired or sleepy enough to get good sleep at night. This study is designed to determine if the medication can "reset" participants' sleep/wake rhythm to a more normal rhythm.
Interventions
- DRUG modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00626210
The ClinicalTrials.gov registry entry for NCT00626210 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Palo Alto Health Care System, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which modafinil is the first listed.
NCT00626210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00626210 about?
NCT00626210 is a clinical study titled "Modafinil Treatment for Sleep/Wake Disturbances in Older Adults". Modafinil, trade named Provigil, is a medication approved by the Food and Drug Administration for the treatment of narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. Each of these problems is characterized by difficulty sleeping at night and excessive daytime sleep...
What is the current status of trial NCT00626210?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2008-02. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00626210?
The interventions under investigation include: modafinil (DRUG).
Who is sponsoring clinical trial NCT00626210?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.